Podcasts

SDBN BUZZ Podcast: Eric Topol: Will AI Improve or Erode the Doctor Patient Relationship?

San Diego Biotechnology Network

Artificial intelligence is already making its way into healthcare and allowing for improvements patient care. The possibilities go way beyond what you may have imagined. In this episode, Dr Eric Topol, Executive Vice President at Scripps Research and the founder and director of Scripps Research Translational Institute, describes what some of those advances might look like for both the doctor and the patient. He thinks there is potential for automated note taking, for example, to give back the gift of time spent with each patient in office visits, something that has decreased significantly since he was in med school.

He is likewise concerned that the savings might be used otherwise (more “productivity”) which would further erode the doctor-patient relationship. Face to face time is important for better outcomes. Listen to this episode to find out what relative value units are and why this may be the last chance for doctors to influence the direction of their profession. Dr Topol is the author of Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again.

SDBN BUZZ Podcast: Three Essentials to Advance Your Life Science Career – And Advice for Employers Too

San Diego Biotechnology Network

Robin Toft is the Chairman and Founder of The Toft Group, an executive search firm and author of the book: We Can: The Executive Woman’s Guide to Career Advancement. In this episode she shares three things you must have to advance your career Confidence, Competence and Connections) and how to develop/deploy them. This episode is packed with good advice. Here are some highlights. You are the CEO of you. You should spend 75% of your time creating excellent value for your company. The other 25% should be spent planning how you can add more. Every CEO is thinking ahead and you should to. Companies value people who can think ahead strategically.

View a Transcript of the Podcast here

Artificial Intelligence in Precision Medicine: State of the Art at Stanford

Prof. Matthew Lungren shares his stories on how he got to where he is now and where his artificial intelligent inspiration for medicine comes from. He also talks about many great collaborations at the Stanford Center in precision medicine and what he’s looking to see more in this field in the next 5 years.

View a Transcript of the Podcast here

Gene Therapy for Rare Disorders

Gene therapy presents a promising path ahead for patients of rare diseases. The United States Food and Drug Administration’s Director of the Center for Biologics Evaluation and Research, Dr. Peter Marks discusses his work advancing production and availability of gene therapies for rare disorders, and the unique challenges to producing efficacious therapeutics in this field.

View a Transcript of the Podcast here

Putting the AI in Wait: Is It Ready to Solve All Our Pathology Problems?

Dr. Richard Levenson discusses the role of AI in digital pathology – what works, and what needs to be done for AI to reach its full potential.

View a Transcript of the Podcast here

Real precision medicine is starting with the patient: Harness patient biology and AI to enable biomarker-driven personalized medicine

Harry Glorikian interviews Niven R. Narain about his approach on how to add more precision to the process of drug development and diagnostic development while engage more reproducibility. Niven also discusses how to use the biomarkers not only as a readout but as a vehicle and an agent to design clinical trials much differently.

View a Transcript of the Podcast here

Mark Stewart and Friends of Cancer Research Target the Tumor Mutational Burden and Pursue Harmonization

Dr. Mark Stewart discusses the role of the tumor mutational burden (TMB) in cancer research and the need for harmonization throughout the process.

View a Transcript of the Podcast here

Personalized Estimation of Motality Risk – Digital Age Makes it a Reality

with Bradley A. Perkins, MD, Co-Founder & CEO, Sapiens Data Science, Inc.

Dr. Bradley Perkins develops a digital platform that can estimate personalized ten year mortality risk. In this podcast, he shares with us what this platform is and how it works to protect and improve the health of individuals and families. In the era of personalized medicine, Dr. Perkins explains what the necessary steps to bring this platform to the general public, gives us other personalized medicine examples and how it will affect the cost of medical care.

Topics include Precision medicine, Personalized medicine, Digital platform, Wellness Prediction, Health data

View a Transcript of the Podcast here

Diagnostic and Clinical Implications of a Targeted NGS panel in Autism Spectrum Disorders

with Yu Jin Park, Specialist, Severance Hospital

Yu Jin Park of Severance Hospital speaks to CHI on March 23, 2017. Mr. Park was a Poster Winner at the Molecular Medicine Tri-conference that ran this past February, 2017.

Topics include using next generation sequencing in a gene panel for Autistic Spectrum Disorder(ASD).

View a Transcript of the Podcast here

Next-Generation Sequencing for Detecting Antimicrobial Resistance

with Romney M. Humphries, Ph.D., D(ABMM), Assistant Professor, UCLA Pathology & Laboratory Medicine, Section Chief of Clinical Microbiology, David Geffen School of Medicine, University of California, Los Angeles

Romney Humphries, Assistant Professor, UCLA Pathology & Laboratory Medicine, Section Chief of Clinical Microbiology, David Geffen School of Medicine, University of California, Los Angeles spoke to CHI to discuss how Next-Generation Sequencing has changed the way scientists detect antimicrobial resistance as well as the challenges scienctists face moving forward.

Dr. Humprhies is one of our speakers at the Molecular Diagnostics for Infectious Disease conference, taking place March 7-9 as part of the Molecular Medicine TriConference. For details, visit TriConference.com/Molecular-Diagnostics-for-Infectious-Disease/

View a Transcript of the Podcast here

Point-of-Care Diagnostics in CVS' MinuteClinics

Daniel R. Kerls, MBA, OTR/L, Director, Ambulatory Operations, CVS MinuteClinic
Alexander Sbordone, Operations Manager, CVS MinuteClinic

CHI's Samantha Lewis speaks with Daniel Kerls, director of ambulatory operations at CVS' Minute Clinic, as well as Alexander Sbordone, who is the Minute Clinic operations manager at CVS. Kerls and Sbordone discuss staffing MinuteClinic, the types of diagnostic tests they seek out, and the future direction of rapid clinics.

Topics Include: Point of care diagnostics, rapid clinics, retail health clinics, MinuteClinic and CVS